Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran; Physiology and Pharmacology Department, Kerman Medical School, Kerman University of Medical Sciences, Kerman, Iran.
Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran; Physiology and Pharmacology Department, Kerman Medical School, Kerman University of Medical Sciences, Kerman, Iran.
Pharmacol Rep. 2019 Jun;71(3):457-464. doi: 10.1016/j.pharep.2019.02.005. Epub 2019 Feb 12.
The aim of this study was to evaluate the effect of vitamin E co-administration with celecoxib in thermal and inflammatory pain in two model of pain assessment including thermal tail flick test of acute pain and formalin induced inflammatory model in adult male rats.
Seventy two male Wistar rats were divided into a vehicle received intraperitoneally olive oil, indomethacin (20 mg/kg), vitamin E (100, 200 and 400 mg/kg), celecoxib (3, 10, 30 and 60 mg/kg) groups, and combination groups received the combination of vitamin E (100 and 200 mg/kg) and celecoxib (3, 10 and 30 mg/kg). All drugs were dissolved in olive oil. Antinociceptive effect in tail-flick was measured using Area Under Curve (AUC) of responses and Maximum Possible Effect (%MPE) and pain score was used for antinociceptive response in formalin test.
Vitamin E and celecoxib changed time course of pain scores in a dose related manner in formalin test but not in tail-flick test. Vitamin E (200 mg/kg) had no effect and merely 60 mg/kg of celecoxib increased %MPE and AUC in tail-flick. The combination of vitamin E (100 or 200 mg/kg) with celecoxib (3 or 10 mg/kg) decreased pain scores compared to vehicle in both phases of formalin test, while in chronic phase (II) the pain scores of combination groups were also decreased compared to vitamin E and celecoxib. However, in tail-flick test the combination of ineffective doses of vitamin E (200 mg/kg) and celecoxib (10 and 30 mg/kg) increased %MPE and AUC compared to vehicle but not compared to celecoxib or vitamin E.
Vitamin E and celecoxib showed a dose related antinociceptive effect in inflammatory but not in thermal model of acute pain. However the co-administration of vitamin E with celecoxib caused a significant increase in the antinociceptive effect which was similar to indomethacin, as a standard anti-inflammatory drug. So we suggest the concomitant use of vitamin E with celecoxib and other NSAIDs for potentiation of both anti- inflammatory and analgesic response, as well as the reduction of cardiovascular side effects of celecoxib.
本研究旨在评估维生素 E 与塞来昔布联合应用于两种疼痛评估模型(急性疼痛的热尾闪烁试验和成年雄性大鼠福尔马林诱导的炎症模型)中热和炎症性疼痛的效果。
72 只雄性 Wistar 大鼠随机分为橄榄油对照组、吲哚美辛(20mg/kg)组、维生素 E(100、200 和 400mg/kg)组、塞来昔布(3、10、30 和 60mg/kg)组和联合组(维生素 E 100 和 200mg/kg 与塞来昔布 3、10 和 30mg/kg 联合)。所有药物均溶于橄榄油中。用反应的曲线下面积(AUC)和最大可能效应(%MPE)测量尾闪烁试验中的镇痛作用,用疼痛评分测量福尔马林试验中的镇痛反应。
维生素 E 和塞来昔布以剂量相关的方式改变了福尔马林试验中疼痛评分的时间过程,但在尾闪烁试验中没有。维生素 E(200mg/kg)无作用,仅 60mg/kg 的塞来昔布增加了尾闪烁试验中的%MPE 和 AUC。与载体相比,维生素 E(100 或 200mg/kg)与塞来昔布(3 或 10mg/kg)的联合减少了福尔马林试验两个阶段的疼痛评分,而在慢性阶段(II),联合组的疼痛评分也低于维生素 E 和塞来昔布。然而,在尾闪烁试验中,与载体相比,无效剂量的维生素 E(200mg/kg)和塞来昔布(10 和 30mg/kg)联合增加了%MPE 和 AUC,但与塞来昔布或维生素 E 相比没有增加。
维生素 E 和塞来昔布在炎症模型中表现出剂量相关的镇痛作用,但在急性热痛模型中没有。然而,维生素 E 与塞来昔布联合使用可显著增加镇痛作用,与标准抗炎药吲哚美辛相似。因此,我们建议同时使用维生素 E 与塞来昔布和其他 NSAIDs,以增强抗炎和镇痛反应,并减少塞来昔布的心血管副作用。